Stock VNSN VANSEN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Vansen Pharma Inc.

Equities

VNSN

US92209Y1010

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Okana Ventures Inc. acquired Factive product from Merus Labs International Inc. for $3.4 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNSN Stock
  4. News Vansen Pharma Inc.
  5. Press Releases